I think you know better then others to see the difference between Telix and these names.
And wouldn't you prefer for others to see the potential valuation of Telix from the execution of 177Lu alone?
What valuation would you put on TLX if they do successfully execute and deliver their 177Lu treatments?
I personally would prefer TLX to be considered and stay overvalued based on future expectations rather then being discounted due to its biotech jargon complexities - and being taken over for a small premium which does not reflect it's future potential.
Radiopharm - anyone know how this compares to TLX?, page-29
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.99 |
Change
0.190(1.07%) |
Mkt cap ! $6.020B | |||
| Open | High | Low | Value | Volume |
| $17.98 | $18.01 | $17.73 | $10.89M | 609.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1237 | $17.98 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.99 | 1159 | 1 |
View Market Depth
| Last trade - 16.10pm 12/08/2024 (20 minute delay) ? |
| TLX (ASX) Chart |